Data / Drug companies / Aspirin 81mg
Aspirin 81mg: 4 companies and 5 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aspirin 81mg is listed in the FDA National Drug Code Directory by 4 companies, with 5 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, chewable; tablet, delayed release; tablet, film coated, and the newest product started marketing on June 5, 2024.
The request: Get every company that lists aspirin 81mg in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 4
- Products
- 5
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Adult Low Dose Aspirin Enteric Coated, Safety Coated Aspirin 81 MG Low Dose
- openFDA record search
- api.fda.gov
Companies that list aspirin 81mg
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Lodaat LLC | 2 | tablet, chewable | Over the counter monograph drugs | June 5, 2024 |
| Allegiant Health | 1 | tablet, film coated | Over the counter monograph drugs | May 9, 2024 |
| Pharbest Pharmaceuticals, Inc. | 1 | tablet, delayed release | Over the counter monograph drugs | February 20, 2019 |
| Ulai Health LLC | 1 | tablet, delayed release | Over the counter monograph drugs | June 28, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 2 | 40% |
| Tablet, delayed release | 2 | 40% |
| Tablet, film coated | 1 | 20% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 5 | 100% |
Pharmacologic classes
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.